Educate. Collaborate. Innovate. TRANSFORMING LIVES TOGETHER
Total Page:16
File Type:pdf, Size:1020Kb
SAN DIEGO, CA • SEPT 20-23, 2019 educate. collaborate. innovate. TRANSFORMING LIVES TOGETHER Make plans now to join us in San Diego at the premier educational and networking event of the year for all plastic surgeons, associates, support professionals and office staff. PSTM19 brings together the best and brightest in our specialty from more than 70 countries. PSTM19 is bigger and better than ever! Register now to make sure you and your team don’t miss out! PlasticSurgeryTheMeeting.com RHINOPLASTYSOCIETY THE FOUNDED 1996 Introducing the surgeon- selected tissue expander1,* The tissue expander with over 30 years of clinical experience is now available in a smooth surface.2 PAIRED FOR PRECISION 100% match to the Natrelle INSPIRA® Collection3 SECURE PLACEMENT 360° tab orientation SMOOTH SURFACE for greater placement Less surface area and support less tissue adherence4 FASTER FILL 4X faster fill with the FOURTÉ™ Expander Fill System5 For more information, visit NatrelleSurgeon.com *Based on surgeon survey data of textured tissue expanders, March 2019 (N = 79). Natrelle ® 133S, 133 Plus, and 133 Tissue Expanders With Natrelle ® 133S, 133 Plus, and 133 Tissue Expanders IMPORTANT Natrelle ® Breast Implants Important Information ® MAGNA-SITE Injection Sites Important Information SAFETY INFORMATION (continued) INDICATIONS INDICATIONS WARNINGS (continued) Natrelle ® Breast Implants are indicated for women for the following: Natrelle ® 133S, 133 Plus, and 133 Tissue Expanders are indicated for: • DO NOT expand if the pressure will compromise wound healing or Breast reconstruction. Breast reconstruction includes primary • Breast reconstruction following mastectomy. vasculature of overlying tissue, or beyond patient or tissue tolerance. reconstruction to replace breast tissue that has been removed due to • Treatment of underdeveloped breasts. Stop filling immediately if tissue damage, wound dehiscence, abnormal cancer or trauma or that has failed to develop properly due to a severe • Treatment of soft tissue deformities. skin pallor, erythema, edema, pain, or tenderness are observed. breast abnormality. It also includes revision surgery to correct or • DO NOT reuse explanted products. improve the result of primary breast reconstruction. IMPORTANT SAFETY INFORMATION • Active infection anywhere may increase risk of periprosthetic CONTRAINDICATIONS IMPORTANT SAFETY INFORMATION ® infection. DO NOT expose the tissue expander or injection needles to Natrelle 133S, 133 Plus, and 133 Tissue Expanders SHOULD NOT be contaminants. Postoperative infections should be treated aggressively. CONTRAINDICATIONS used in patients: • Adverse reactions may require premature explantation. Not for women with active infection anywhere in their body, with • Who already have implanted devices that would be affected by a • When using suturing tabs be careful to avoid piercing the shell. Use a existing cancer or precancer of their breast who have not received magnetic field (eg, pacemakers, drug infusion devices, artificial new one if damage occurs. adequate treatment for those conditions, and women who are currently sensing devices). • Natrelle ®_133S, 133 Plus, and 133 Tissue Expanders are temporary pregnant or nursing. • Whose tissue at the expansion site is determined to be unsuitable. devices and are not to be used for permanent implantation or beyond WARNINGS • Who have an active infection or a residual gross tumor at the 6 months. Tissue expansion in breast reconstruction typically requires Breast implants are not lifetime devices and breast implantation may not expansion site. 4 months to 6 months. be a one-time surgery. Avoid damage during surgery: Avoid excessive • Undergoing adjuvant radiation therapy. force, minimize handling of the implant, and use care when using surgical • Whose physiological condition (eg, sensitive over- or underlying PRECAUTIONS Active infections may need to be treated and resolved before surgery. instruments near the breast implant. For more information, please see the anatomy, obesity, smoking, diabetes, autoimmune disease, full Directions for Use. hypertension, chronic lung or severe cardiovascular disease, or Allergan relies on the surgeon to know and follow proper surgical osteogenesis imperfecta) or use of certain drugs (including those that procedures and carefully evaluate patient suitability using standard PRECAUTIONS interfere with blood clotting or affect tissue viability) poses an unduly practice and individual experience. Avoid damage to the tissue expander Safety and effectiveness have not been established in patients with high risk of surgical and/or postoperative complications. and use a sterile backup in case of damage. Pay careful attention to the following: autoimmune diseases, a compromised immune system, • Who are psychologically unsuitable. tissue tolerance and hemostasis during surgery. Expansion should planned radiation therapy to the breast or planned chemotherapy proceed moderately and never beyond patient or tissue tolerance. Avoid following breast implant placement, conditions/medications that interfere WARNINGS contamination in any postoperative procedure. with wound healing and blood clotting, reduced blood supply to breast • DO NOT use Natrelle ® 133S, 133 Plus, and 133 Tissue Expanders in ADVERSE REACTIONS tissue, or a clinical diagnosis of depression, other mental health disorders, patients who already have implanted devices that would be affected body dysmorphic disorder, or eating disorders. by a magnetic field (see Contraindications) because the MAGNA-SITE® Deflation, tissue damage, infection, extrusion, hematoma/seroma, integrated injection site contains a strong rare-earth, permanent capsular contracture, premature explantation, displacement, effects ADVERSE EVENTS magnet. Diagnostic testing with Magnetic Resonance Imaging (MRI) on bone, pain, sensation, distortion, inadequate tissue flap, and Key adverse events are reoperation, implant removal with or without is contraindicated in patients with Natrelle ® 133S, 133 Plus, and 133 inflammatory reaction. replacement, implant rupture with silicone-filled implants, implant Tissue Expanders in place. For more information, please visit www.allergan.com/labeling deflation with saline-filled implants, and capsular contracture Baker • DO NOT alter the tissue expander or use adulterated fill. Fill only with /usa.htm. To report a problem with Natrelle ®, please call Allergan Grade III/IV. sterile saline for injection as described in INSTRUCTIONS FOR USE. at 1-800-433-8871. For more information see the full Directions for Use at DO NOT expose to contaminants. ® www.allergan.com/labeling/usa.htm. To report a problem Natrelle 133S, 133 Plus, and 133 Tissue Expanders are available by ® prescription only. with Natrelle Breast Implants, please call Allergan at 1-800-433-8871. Natrelle ® Breast Implants are available by prescription only. References: 1. Data on file, Allergan, March 2019; Plastic Surgery Monthly Tracker: Breast Implants, Tissue Expanders, ADMs, and Fat Transfer.2. Data on file, Allergan, July 14, 1986; FDA Section 510(k) marketing approval letter. 3. Data on file, Allergan, January 6, 2017; Study Report MD16076-DV.4. O’Shaughnessy K. Evolution and update on current devices for prosthetic breast reconstruction. Gland Surgery. 2015;4(2):97-110. 5. Data on file, Allergan, January 4, 2016; Protocol MM-1225-FR. © 2019 Allergan. All rights reserved. All trademarks are the property of their respective owners. Natrelle.com NAT123799 04/19 183011 183011_133S_Ad_RegBrochure_ST.indd 1 4/18/19 11:06 AM “The Meeting for Everyone” heads to San Diego in September We are excited to invite you to Plastic Surgery The Meeting 2019! San Diego is known for its spectacular beaches, beautiful weather and vast array of Alan Matarasso, MD President social activities. Just like PSTM19, this city has something for everyone! American Society of Plastic Surgeons (ASPS) First and foremost, we are excited to share that “The Meeting With More” has gotten even bigger this year. We’re pleased to formally welcome the American Society of Plastic Surgery Professionals (ASPSP) and The Rhinoplasty Society (TRS) as PSTM partners. PSTM now serves as the official annual meeting for ASPSP, the society for plastic surgery office professionals. ASPSP has worked together with this year’s annual meeting committee to design programming that will benefit your entire office, leading to higher Andrea Pusic, MD patient satisfaction and more efficient practices! TRS, while always a vital President pre-conference partner, has brought its expertise to the rhinoplasty The Plastic Surgery Foundation (The PSF) programming that is included as part of the PSTM19 registration fee. TRS will now be hosting a full day of rhinoplasty education as part of PSTM19 on Friday. That’s right – we have a full day of educational programming on Friday! Here are some other things you can look forward to at PSTM19: • FOUR FULL DAYS (Friday through Monday) of education including more than 210 sessions covering aesthetic, reconstructive, practice management, wellness and research and innovation topics Peter J. Taub, MD President • A jam-packed exhibit hall with the latest products and services you need American Society of for your practice Maxillofacial Surgeons (ASMS) • Networking receptions, luncheons and events to help you connect with friends and colleagues • Opening Ceremonies and Welcome Reception will take advantage of the beautiful San Diego weather, views of the gorgeous bay and a feel-good musical performance.